Vernouillet, France

Gilles Serrure



Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gilles Serrure

Introduction

Gilles Serrure is a notable inventor based in Vernouillet, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of optical enantiomers. His work has implications for the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

Latest Patents

Gilles Serrure holds a patent for a process related to the preparation of crystalline forms of optical enantiomers of modafinil. This invention pertains to a polymorphic form of (−)-modafinil, which produces a powder X-ray diffraction spectrum with intensity peaks corresponding to interplanar spacings of about 8.54, 4.56, and 3.78 Å. This patent highlights his expertise in the field and his commitment to advancing pharmaceutical science. He has 1 patent to his name.

Career Highlights

Throughout his career, Gilles has worked with prominent companies in the pharmaceutical industry, including Teva Santé. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Gilles has collaborated with several professionals in his field, including Olivier Neckebrock and Laurent Courvoisier. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Gilles Serrure's contributions to the field of pharmaceuticals through his innovative patent and collaborations with industry professionals underscore the vital role of inventors in advancing healthcare solutions. His work exemplifies the impact of innovation on improving medical treatments and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…